30-May-2011 - German transdermal drug developer, Labtec, has opened what it claims is Europe’s most modern manufacturing facility for the production of transdermal drug delivery systems (TDS) and oral dispersible films (ODF) using its proprietary RapidFilm technology.
24-May-2011 - Serina Therapeutics has developed a new way of synthesizing polyoxazoline (POZ) polymers for drug delivery applications that, it claims, is free of the drawbacks that have hampered previous production methods.
23-May-2011 - SAFC, the custom manufacturing and business services wing of Sigma Aldritch, has announced a licensing agreement with biotech company, Agilent Technologies, for the sale of its nucleic acids synthesis products and technologies.
23-May-2011 - Neuland Laboratories doubled its operating profit in the fourth quarter, continuing the full year trend, as API sales improved.
19-May-2011 - The EDQM has revised its policy on withdrawal of API or excipient certification to clarify the appeal process.
19-May-2011 - Novozymes Biopharma will launch a new grade of its Bacillus-derived hyaluronic acid (HA) for ophthalmic delivery applications later this year.
18-May-2011 - Californian biotech tool manufacturer Life Technologies has teamed with German contract research organisation (CRO) ProBiogen to release a range of royalty-free Gibco Freedom Cell Line Development Kits.
12-May-2011 - Pharmaceutical intermediate sales helped Codexis in Q1 but the US biocatalysis specialist still posted a net loss for the quarter on higher R&D spending
12-May-2011 - Quality issues slowed first quarter revenue growth at Teva but, with one plant resuming shipping and another awaiting re-inspection, sales are expected to pick up.
11-May-2011 - Jubilant Life Sciences is to build an intermediate plant and expand production to continue double-digit growth seen in the fourth quarter.
11-May-2011 - Aurobindo Pharma is considering demerging its API and formulation businesses to unlock value and better serve clients.
10-May-2011 - The FDA and USP have expanded their collaboration to ensure the quality of medicines by modernising tests and standards.
10-May-2011 - Chemicals supplier Aceto Corp has its sights set on opportunities in the generic drug sector after soaring active pharmaceutical ingredient (API) and intermediates sales helped it to a strong set of quarterly financials.
09-May-2011 - Carbogen Amcis’s Indian plant has met industrial standards for the containment and handling of highly potent active pharmaceutical ingredients (HPAPI).
09-May-2011 - Cambrex recorded double-digit sales growth in the first quarter as the API producer overcame problems it faced a year ago.
05-May-2011 - Albany Molecular Research (AMRI) posted a modest net loss on costs and restructuring charges, but saw revenue grow considerably in the first quarter thanks to contracting business and royalties.
05-May-2011 - Aptuit is manufacturing Phase III materials for Iroko using a nanoformulation technology that produces fast-dissolving particles.
03-May-2011 - International Specialty Products (ISP) has announced plans to raise its prices by 10 per cent in response to increasing raw material and energy costs.
03-May-2011 - in-PharmaTechnologist presents a round up of biopharm manufacturing expansions, including details of new plants for OmniLytics and Morphotek.
02-May-2011 - The second draft of Excipact, a set of certification standards for drug excipient producers being developed by the EFCG, FECC, IPEC and PQD, has been sent to industry stakeholders for consultation.
26-Apr-2011 - US-based vaccine specialist, Caliber Biotherapeutics, has opened the world’s largest modular, plant-made pharmaceutical manufacturing facility at its headquarters in Bryan, Texas.
26-Apr-2011 - Biogen Idec and Merck & Co are expanding capabilities and adding jobs in Durham, North Carolina, US.
19-Apr-2011 - US-based tissue regeneration specialist, Organogensis, has broken ground on the construction of the world’s largest automated living cell manufacturing plant in Canton, Massachusetts.
19-Apr-2011 - Continuous manufacturing offers significant advantages for drug production in terms of quality and efficiency, but more research and regulatory input is needed to help the pharmaceutical sector reap the benefits according to ISP.
18-Apr-2011 - MENA-focused drug manufacturer, Hikma, has entered into a strategic partnership with Indian API and intermediates business, Unimark Remedies.